Henry Schein, Inc. $HSIC Stake Boosted by Alliancebernstein L.P.

Key Points

• Alliancebernstein L.P. increased its stake in Henry Schein, Inc. by 21.9% during Q1, acquiring 39,188 additional shares, bringing its total holdings to 218,340 shares valued at approximately $14.95 million.
• Recent analyst reports indicate a mixed outlook on Henry Schein's stock, with price targets lowered and a consensus rating of "Hold," while the average price target is set at $76.67.
• Henry Schein reported Q2 earnings of $1.10 per share, missing estimates, but showed a revenue increase of 3.3% year-over-year, totaling $3.24 billion.

Alliancebernstein L.P. raised its position in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 21.9% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 218,340 shares of the company's stock after acquiring an additional 39,188 shares during the period. Alliancebernstein L.P. owned approximately 0.18% of Henry Schein worth $14,954,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Investment Management Corp VA ADV purchased a new stake in Henry Schein during the fourth quarter valued at about $32,000. Rakuten Securities Inc. purchased a new stake in Henry Schein during the first quarter valued at about $34,000. Whittier Trust Co. grew its position in Henry Schein by 714.3% during the first quarter. Whittier Trust Co. now owns 798 shares of the company's stock valued at $55,000 after acquiring an additional 700 shares during the period. Quarry LP purchased a new stake in Henry Schein during the first quarter valued at about $71,000. Finally, UMB Bank n.a. grew its position in Henry Schein by 23.2% during the first quarter. UMB Bank n.a. now owns 1,066 shares of the company's stock valued at $73,000 after acquiring an additional 201 shares during the period. Hedge funds and other institutional investors own 96.62% of the company's stock.

Henry Schein Stock Down 1.5%

Henry Schein stock traded down $1.02 during midday trading on Wednesday, hitting $67.37. The stock had a trading volume of 1,569,064 shares, compared to its average volume of 1,398,476. The company has a current ratio of 1.41, a quick ratio of 0.78 and a debt-to-equity ratio of 0.51. The stock has a market cap of $8.17 billion, a P/E ratio of 21.73, a P/E/G ratio of 2.26 and a beta of 0.86. Henry Schein, Inc. has a 12 month low of $60.56 and a 12 month high of $82.49. The business has a fifty day moving average price of $68.98 and a 200 day moving average price of $69.40.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its quarterly earnings data on Tuesday, August 5th. The company reported $1.10 earnings per share for the quarter, missing the consensus estimate of $1.19 by ($0.09). The firm had revenue of $3.24 billion during the quarter, compared to the consensus estimate of $3.22 billion. Henry Schein had a net margin of 3.05% and a return on equity of 14.36%. The firm's quarterly revenue was up 3.3% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.23 earnings per share. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. Research analysts predict that Henry Schein, Inc. will post 4.74 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on HSIC. UBS Group lowered their price target on Henry Schein from $75.00 to $70.00 and set a "neutral" rating for the company in a research report on Wednesday, August 6th. Barrington Research reduced their price objective on Henry Schein from $86.00 to $78.00 and set an "outperform" rating on the stock in a research note on Wednesday, August 6th. JPMorgan Chase & Co. reduced their price objective on Henry Schein from $80.00 to $76.00 and set an "overweight" rating on the stock in a research note on Thursday, August 7th. Stifel Nicolaus restated a "hold" rating and set a $75.00 price objective (down previously from $80.00) on shares of Henry Schein in a research note on Friday, July 25th. Finally, Robert W. Baird restated a "neutral" rating and set a $72.00 price objective (down previously from $82.00) on shares of Henry Schein in a research note on Monday, July 14th. Five investment analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus target price of $76.67.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.